1500 E Medical Center Dr
Ann Arbor, MI 48109
Available to mentor
Dr. Mierzwa has 13 years of clinical experience in treatment of head and neck cancer. Her clinical research interests have included novel chemoradiation regimens for head and neck cancers, as well as imaging markers and biomarkers of tumor response to radiation and toxicity. Specifically, she collaborates with the Departments of Otolaryngology and Medical Oncology to develop clinical trials to identify for oropharynx cancer patients who may be eligible for de-escalation of chemoradiation or may require intensified therapy. She is also the PI of an ongoing novel oropharynx cancer surveillance and survivorship protocol.
RadOnc Bio
-
ResidencyUniversity of Cincinnati, Division of Radiology, 2008
-
InternshipChrist Hospital, Internal Medicine, 2004
-
MDUniversity of Cincinnati - College of Medicine, 231 Albert Sabin Way, 2003
-
MSVanderbilt Universtiy, 2201 West End Ave, 1999
-
BSVanderbilt University, Nashville, 1997
-
Center MemberRogel Cancer Center
- Advanced imaging techniques and imaging markers of response to radiotherapy in head and neck cancer
- Development of prognostic and predictive biomarkers in head and neck cancer
- Outcome modelling for tumor control and toxicity in head and neck cancer treated with radiotherapy Clinical trial development to de-escalate radiotherapy in oropharynx cancer
- Clinical trial development using imaging markers to improve tumor control in high-risk head and neck cancer treated with radiotherapy
- Head and neck cancer
-
Nieto JD, Chang DT, Paradis KC, DuRussel E, Matuszak MM, Rosen BS, Prisciandaro JI, Matrosic C, Kashani R, Evans JR, Jackson WC, Lawrence TS, Jolly S, Mierzwa ML, Mayo C. International Journal of Radiation Oncology • Biology • Physics, 2024 Oct; 120 (2): e171Proceeding / Abstract / PosterApplication of Standardized Tissue Repair Discount Factors to Guide Spinal Cord Dose in Reirradiation
DOI:10.1016/j.ijrobp.2024.07.385 -
Mayo C, Su S, Rosen BS, Covington E, Zhang Z, Lawrence TS, Fuller CD, Brock KK, Shah JL, Mierzwa ML. International Journal of Radiation Oncology • Biology • Physics, 2024 Oct; 120 (2): s41 - s42.Proceeding / Abstract / PosterNovel Statistical-AI Method to Automate Discovery of Predictive Factors and Thresholds for 3 Year Survival, Dysphagia and Xerostomia for Patients with Head and Neck Cancers
DOI:10.1016/j.ijrobp.2024.07.062 -
Benjamin WJ, Feng AL, Heft Neal M, Bellile E, Casper KA, Malloy KM, Rosko AJ, Stucken CL, Prince ME, Mierzwa ML, Taylor JMG, Eisbruch A, Spector ME, Wolf GT, Swiecicki PL, Worden FP, Chinn SB. Oral Oncol, 2024 Sep; 156: 106917Journal ArticleUtility of bioselection with neoadjuvant chemotherapy for organ preservation in patients with T4 laryngeal cancer.
DOI:10.1016/j.oraloncology.2024.106917 PMID: 38945011 -
Gharzai LA, Mierzwa ML, Stepan KO, Cella D, Peipert JD. Support Care Cancer, 2024 Aug 6; 32 (9): 575Journal ArticleValidity of a single-item indicator of treatment side effect bother in patients with head and neck cancer.
DOI:10.1007/s00520-024-08775-x PMID: 39107440 -
Swiecicki PL, Bellile E, Dragovic AF, McHugh J, Udager A, Mierzwa ML, Shah J, Heft-Neal M, Rosko A, Malloy KM, Casper K, Chinn SB, Shuman AG, Stucken C, Chepeha DB, Wolf GT, Bradford CR, Eisbruch A, Prince ME, Worden FP, Spector ME. 2024 Jun 3;Additional ScholarshipData from Upfront Neck Dissection for Treatment Selection and Improvement in Quality of Life as a Novel Treatment Paradigm for Deintensification in HPV<sup>+</sup> OPSCC
DOI:10.1158/1078-0432.c.7265749 -
Swiecicki P. 2024 Jun;Additional ScholarshipData from Upfront Neck Dissection for Treatment Selection and Improvement in Quality of Life as a Novel Treatment Paradigm for Deintensification in HPV+ OPSCC
-
Swiecicki PL, Bellile E, Dragovic AF, McHugh J, Udager A, Mierzwa ML, Shah J, Heft-Neal M, Rosko A, Malloy KM, Casper K, Chinn SB, Shuman AG, Stucken C, Chepeha DB, Wolf GT, Bradford CR, Eisbruch A, Prince ME, Worden FP, Spector ME. 2024 Jun 3;Additional ScholarshipSupplementary Table S1 from Upfront Neck Dissection for Treatment Selection and Improvement in Quality of Life as a Novel Treatment Paradigm for Deintensification in HPV<sup>+</sup> OPSCC
DOI:10.1158/1078-0432.25956250 -
Swiecicki PL, Bellile E, Dragovic AF, McHugh J, Udager A, Mierzwa ML, Shah J, Heft-Neal M, Rosko A, Malloy KM, Casper K, Chinn SB, Shuman AG, Stucken C, Chepeha DB, Wolf GT, Bradford CR, Eisbruch A, Prince ME, Worden FP, Spector ME. 2024 Jun 3;FigureSupplementary Table S1 from Upfront Neck Dissection for Treatment Selection and Improvement in Quality of Life as a Novel Treatment Paradigm for Deintensification in HPV<sup>+</sup> OPSCC
DOI:10.1158/1078-0432.25956250.v1